Find an Eye MD near you!

Alcon reports that the U.S. FDA has approved its AcrySof IQ aspheric IOL with the UltraSert pre-loaded delivery system.

A complete work-up immediately following nonarteritic central retinal artery occlusion picks up undiagnosed cardiovascular risk factors in almost 80% of patients.

Results from a phase 3 trial shows vision restoration in patients with RPE65-mediated inherited retinal dystrophies.

The 2-piece system allows for easy exchange of the optic to correct residual refractive error during surgery or 3 months postop.

InnFocus secured $32.8 million in Series C financing to fund the study of its MicroShunt glaucoma drainage system.

A 60-year-old woman is the first of 10 patients in the UK to receive embryonic stem cell therapy for AMD.